Insulin glargine and Ultravist Injection
Determining the interaction of Insulin glargine and Ultravist Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: iopromide
Brand name: Ultravist
Synonyms: Ultravist
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Ultresa
- Insulin glargine-Umeclidinium
- Insulin glargine-Umeclidinium and vilanterol
- Insulin glargine-Umeclidinium and vilanterol Inhalation
- Insulin glargine-Umeclidinium Bromide
- Insulin glargine-Umeclidinium Inhalation
- Ultravist Injection-Insulin Glargine (U-100) Cartridge Systems and Pens
- Ultravist Injection-Insulin Glargine (U-100) Vials
- Ultravist Injection-Insulin Glargine (U-300) Pens
- Ultravist Injection-Insulin glargine and lixisenatide
- Ultravist Injection-Insulin glargine and lixisenatide Subcutaneous
- Ultravist Injection-Insulin glargine, recombinant Subcutaneous